SCLX Q2 2023 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q2 2023 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$13M+58.7% YoY

Gross Profit

$8M66.8% margin

Operating Income

-$23M-181.3% margin

Net Income

-$27M-211.8% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

+18.9%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$126M

Total Liabilities

$116M

Stockholders' Equity

$10M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$8M	+58.7%
Gross Profit	$8M	$6M	+31.4%
Operating Income	-$23M	-$11M	-98.9%
Net Income	-$27M	-$18M	-49.4%